Advancements in Cardiac Marker Testing Emerging as a Key Industry Trend

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Cardiac Marker Testing Market Evolve From 2026 To 2030?

The cardiac marker testing market has seen rapid expansion in recent years. This market is projected to grow from $7.19 billion in 2025 to $7.93 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. In the past, this growth was influenced by factors such as the limited availability of high-sensitivity cardiac marker tests, a reliance on centralized laboratory testing, the increasing prevalence of cardiovascular diseases, growing awareness among healthcare providers, and conventional manual diagnostic practices.

The cardiac marker testing market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $11.61 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.0%. The projected increase can be attributed to several factors such as the development of automated and portable cardiac marker testing devices, the increasing integration of digital health platforms, the growing adoption of point-of-care diagnostics, an expanding geriatric population coupled with cardiovascular risks, and improvements in the sensitivity of reagents and kits. Prominent developments expected during this period include a higher uptake of high-sensitivity cardiac biomarker tests, the expansion of point-of-care testing facilities, the integration of automated analyzers and immunoassay systems, a wider application of cardiac marker testing in preventive cardiology, and a rising need for portable diagnostic devices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cardiac Marker Testing Market?

The increasing occurrence of cardiovascular diseases is projected to drive the growth of the cardiac marker testing market in the future. Cardiovascular diseases (CVDs) are a category of conditions impacting the heart and blood vessels, including ailments such as coronary artery disease, heart failure, and stroke. The escalation in cardiovascular disease cases is attributed to an unhealthy diet, insufficient physical activity, tobacco consumption, harmful alcohol use, and air pollution. Cardiac marker testing is vital for cardiovascular diseases to precisely diagnose, evaluate the seriousness, and track the advancement or efficacy of treatment for heart conditions by detecting specific biomarkers released during myocardial injury. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, up 4.0% from 224.4 per 100,000 when compared to 2023. Consequently, the rising incidence of cardiovascular diseases is a primary stimulant for the cardiac marker testing market.

Which Segment Areas Are Covered In The Cardiac Marker Testing Market Analysis?

The cardiac marker testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments

2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Biomarker Types

3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents

2) By Instruments: Point-Of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices

What Key Developments And Trends Are Impacting The Cardiac Marker Testing Market?

Leading companies within the cardiac marker testing market are concentrating on creating advanced technological products, such as cardiac assays. These assays are diagnostic tools designed to measure biomarkers or other indicators in blood or samples, aiming to provide crucial, accurate data on heart health and function, diagnose cardiovascular diseases, or evaluate the risk of heart-related conditions. For instance, in October 2023, Mindray, a medical device company based in China, introduced its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay stands out for its remarkable sensitivity, precision, and reliability, surpassing basic requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL) while maintaining an imprecision coefficient of variation (CV) under 5% at the 99th URL, making it highly effective in identifying myocardial injury. Mindray’s NT-proBNP assay serves as a significant cardiac marker for heart failure, exhibiting high precision with a coefficient of variation (CV) of =5%. It also effectively reduces interference from 55 common heart disease medications, thereby ensuring precise detection and management of heart failure.

Which Global Companies Are Actively Competing In The Cardiac Marker Testing Market?

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC, Boditech Med Inc., Response Biomedical Corp.

Read the full cardiac marker testing market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report

What Are The Leading Geographic Regions In The Cardiac Marker Testing Market?

North America was the largest region in the cardiac marker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Marker Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19358&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Testing Market 2026, By The Business Research Company

Ventricular Assist Device Market Report 2026

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Left Ventricular Assist Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/left-ventricular-assist-devices-global-market-report

Interventional Cardiology Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-cardiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795